Veterinary CRO Market Poised to Exceed USD 1.6 Billion by 2035 Amid Rising Animal Health Research

The global veterinary CRO market was valued at approximately USD 770.8 million in 2024 and is projected to grow at a CAGR of 7.1% from 2025 to 2035. Driven by increasing demand for veterinary drug development, rising animal health research, and the growing need for specialized contract research services, the market is expected to cross USD 1.6 billion by the end of 2035.

Ongoing trend of pet ownership, growing awareness of animal health, technological innovations in veterinary medicine and diagnostics, and increased investment in research and development activities for animal drugs are factors anticipated to boost the veterinary CRO market.

Review significant findings and insights from our Report in this sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86567

Market Overview

Veterinary Contract Research Organizations (CROs) play a significant role in research, development, and approval of veterinary products such as pharmaceuticals, vaccines, and medical devices. Veterinary CROs are experts in giving a vast array of services that help the research and development processes involved in getting new animal health products on the market. They include preclinical research, clinical trial management, regulatory affairs, and post-market surveillance.

Preclinical trials imply laboratory research and toxicology testing to understand how a product behaves with biological systems. After preclinical trials are conducted, veterinary CROs oversee clinical trials, which, in various phases, accrue data on the performance of the product among population of targeted animals.

Such experiments are planned meticulously to meet the regulatory requirements of organizations like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA).

Key Market Growth Drivers

• Increasing R&D Outsourcing by Animal Health Companies: Veterinary pharmaceutical sponsors are leveraging specialized CRO networks to manage rising clinical trial complexities, reduce internal fixed overheads, and streamline regulatory filings.
• Surging Pet Humanization & Health Expenditure: Expanding pet ownership and willingness to invest in advanced treatments for chronic canine and feline diseases (e.g., cancer, arthritis) are accelerating clinical pipelines.
• Emergence of Complex Biologics & Vaccines: Rising adoption of monoclonal antibodies, biological therapeutics, and next-generation animal vaccines requires advanced laboratory capabilities and specialized trial infrastructure.
• Focus on Zoonotic Disease Surveillance & Livestock Safety: Heightened regulatory focus on livestock disease management and food supply safety drives demand for high-containment study protocols and residue studies.

Analysis of Key Players

The competitive landscape consists of specialized animal health contract research providers and global multi-disciplinary CROs:

• Charles River Laboratories
• IDEXX Laboratories, Inc.
• BioAgile Therapeutics Private Limited
• Royal GD
• KLIFOVET GmbH
• Argenta Holdco Limited
• Cebiphar
• Clinvet
• STATKING Clinical Services
• OCRvet
• LÖHLEIN & WOLF VET RESEARCH
• VETSPIN SRL
• Inotiv
• Knoell
• Cloudbyz

Key Player Strategies

• Strategic Realignment & Full-Service Integration: Restructuring platforms to offer seamless, end-to-end R&D lifecycle support—from early-stage discovery and toxicology to clinical trials and dossier submission.
• Adoption of AI & Digital Trial Management: Integrating decentralized clinical trial software, digital biomarkers, and data analytics to improve trial data accuracy and shorten submission timelines.
• Facility Expansion & Capacity Upgrades: Investing in specialized Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) compliant facilities to handle bioanalytical testing for novel biopharmaceuticals.

Access detailed insights by visiting our full report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=86567

Market Challenges & Opportunities

Challenges

• Fragmented Regional Regulations: Varied regulatory guidelines across global jurisdictions (such as the US FDA, EMA, and Asia-Pacific authorities) can complicate international study coordination and increase compliance costs.
• High Operational Costs & Specialized Facility Shortages: Managing biosafety-level containment facilities and sourcing specialized veterinary research talent present persistent operational constraints.

Opportunities

• Digital Therapeutics & Decentralized Clinical Trials: Utilizing wearable health monitoring sensors in animal field trials to collect real-time physiological data remotely.
• Rapid Expansion Across Asia-Pacific: Rising commercial livestock production and increasing pet ownership in emerging Asian economies offer high-growth regional potential.

Market Segmentation

• Service Type
• Clinical Trial Services
• Market Authorization and Regulatory Support
• Toxicology Services
• Pharmacokinetic Services
• Laboratory Pathology Services
• Others (Bioanalytical Services, etc.)
• Animal Type
• Companion Animals
• Dogs
• Cats
• Others (Rabbits, etc.)
• Livestock Animals
• Cattle
• Pigs
• Sheep & Goat
• Others (Poultry, etc.)
• Therapeutic Area
• Infectious Diseases
• Orthopedic Disorders
• Gastrointestinal Disorders
• Dermatology
• Oncology
• Others (Neurology, etc.)

Buy this Premium Research Report to gain valuable industry intelligence – https://www.transparencymarketresearch.com/checkout.php?rep_id=86567<ype=S

Frequently Asked Questions

·        How big was the global veterinary CRO market in 2024?

The global veterinary CRO market was valued at US$ 770.8 Mn in 2024.

·        How big will the global veterinary CRO business be in 2035?

The global veterinary CRO business is projected to reach more than US$ 1.6 Bn by the end of 2035.

·        What are the factors driving the veterinary CRO market?

Increasing pet ownership, growing awareness about animal health, and innovations in veterinary medicine and diagnostics.

·        What will be the CAGR of the global veterinary CRO industry during the forecast period?

The CAGR is anticipated to be 7.1% from 2025 to 2035.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com  

Sales Inquiries: sales@transparencymarketresearch.com  

Media Inquiries: media@transparencymarketresearch.com